4-54274888-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_006206.6(PDGFRA):​c.1701A>G​(p.Pro567Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.993 in 1,613,940 control chromosomes in the GnomAD database, including 795,435 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P567P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.97 ( 71320 hom., cov: 31)
Exomes 𝑓: 1.0 ( 724115 hom. )

Consequence

PDGFRA
NM_006206.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -3.56

Publications

80 publications found
Variant links:
Genes affected
PDGFRA (HGNC:8803): (platelet derived growth factor receptor alpha) This gene encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer or a heterodimer, composed of both platelet-derived growth factor receptor alpha and beta polypeptides. Studies suggest that this gene plays a role in organ development, wound healing, and tumor progression. Mutations in this gene have been associated with idiopathic hypereosinophilic syndrome, somatic and familial gastrointestinal stromal tumors, and a variety of other cancers. [provided by RefSeq, Mar 2012]
PDGFRA Gene-Disease associations (from GenCC):
  • gastrointestinal stromal tumor
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • polyps, multiple and recurrent inflammatory fibroid, gastrointestinal
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Genomics England PanelApp
  • congenital heart disease
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • isolated cleft palate
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BP6
Variant 4-54274888-A-G is Benign according to our data. Variant chr4-54274888-A-G is described in ClinVar as Benign. ClinVar VariationId is 259949.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.56 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.992 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006206.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PDGFRA
NM_006206.6
MANE Select
c.1701A>Gp.Pro567Pro
synonymous
Exon 12 of 23NP_006197.1P16234-1
PDGFRA
NM_001347828.2
c.1776A>Gp.Pro592Pro
synonymous
Exon 13 of 24NP_001334757.1
PDGFRA
NM_001347830.2
c.1740A>Gp.Pro580Pro
synonymous
Exon 12 of 23NP_001334759.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PDGFRA
ENST00000257290.10
TSL:1 MANE Select
c.1701A>Gp.Pro567Pro
synonymous
Exon 12 of 23ENSP00000257290.5P16234-1
ENSG00000282278
ENST00000507166.5
TSL:2
c.1018-37A>G
intron
N/AENSP00000423325.1A0A0B4J203
PDGFRA
ENST00000509092.5
TSL:1
n.1519A>G
non_coding_transcript_exon
Exon 11 of 15

Frequencies

GnomAD3 genomes
AF:
0.967
AC:
147117
AN:
152124
Hom.:
71292
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.890
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.985
Gnomad ASJ
AF:
0.993
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.999
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.981
Gnomad NFE
AF:
0.998
Gnomad OTH
AF:
0.971
GnomAD2 exomes
AF:
0.990
AC:
248680
AN:
251180
AF XY:
0.992
show subpopulations
Gnomad AFR exome
AF:
0.885
Gnomad AMR exome
AF:
0.991
Gnomad ASJ exome
AF:
0.994
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
0.998
Gnomad OTH exome
AF:
0.992
GnomAD4 exome
AF:
0.995
AC:
1454661
AN:
1461698
Hom.:
724115
Cov.:
44
AF XY:
0.996
AC XY:
723988
AN XY:
727152
show subpopulations
African (AFR)
AF:
0.877
AC:
29369
AN:
33474
American (AMR)
AF:
0.990
AC:
44272
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.993
AC:
25966
AN:
26136
East Asian (EAS)
AF:
1.00
AC:
39699
AN:
39700
South Asian (SAS)
AF:
0.999
AC:
86208
AN:
86258
European-Finnish (FIN)
AF:
1.00
AC:
53413
AN:
53416
Middle Eastern (MID)
AF:
0.985
AC:
5681
AN:
5768
European-Non Finnish (NFE)
AF:
0.999
AC:
1110410
AN:
1111836
Other (OTH)
AF:
0.988
AC:
59643
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
373
745
1118
1490
1863
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21662
43324
64986
86648
108310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.967
AC:
147194
AN:
152242
Hom.:
71320
Cov.:
31
AF XY:
0.968
AC XY:
72095
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.889
AC:
36916
AN:
41522
American (AMR)
AF:
0.985
AC:
15055
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.993
AC:
3445
AN:
3470
East Asian (EAS)
AF:
1.00
AC:
5159
AN:
5160
South Asian (SAS)
AF:
0.999
AC:
4813
AN:
4818
European-Finnish (FIN)
AF:
1.00
AC:
10618
AN:
10618
Middle Eastern (MID)
AF:
0.980
AC:
288
AN:
294
European-Non Finnish (NFE)
AF:
0.998
AC:
67935
AN:
68044
Other (OTH)
AF:
0.971
AC:
2053
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
227
453
680
906
1133
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.984
Hom.:
64981
Bravo
AF:
0.961
Asia WGS
AF:
0.986
AC:
3430
AN:
3478
EpiCase
AF:
0.998
EpiControl
AF:
0.998

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Gastrointestinal stromal tumor (2)
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Carcinoma of colon (1)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
-
1
Idiopathic hypereosinophilic syndrome (1)
-
-
1
Squamous cell lung carcinoma (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
0.093
DANN
Benign
0.40
PhyloP100
-3.6
Mutation Taster
=67/33
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1873778; hg19: chr4-55141055; COSMIC: COSV99955338; COSMIC: COSV99955338; API